Bromazolam Blood Concentrations in Postmortem Cases—A British Columbia Perspective
Authors:
- 27 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 47 (4) , 385-392
Abstract
Bromazolam is a designer benzodiazepine that was first detected in British Columbia in January 2021. Postmortem cases were analyzed using a comprehensive blood drug screening procedure by liquid chromatography–high-resolution mass spectrometry before being retrospectively analyzed using an in-house novel psychoactive substances data processing method. Bromazolam was detected in 41 postmortem cases in 2021 and quantitatively confirmed by standard addition, using liquid chromatography–tandem mass spectrometry. The mean bromazolam concentration observed was 11.4 ± 53.7 ng/mL (median concentration: 1.6 ng/mL), with a range from 0.5 to 319.3 ng/mL and the majority of cases co-occurring with fentanyl. These low concentrations may be indicative of a presumed enhancement of opioid effects, rather than being used as a stand-alone drug. Bromazolam was always detected with opioids (fentanyl and carfentanil), stimulants (methamphetamine) and/or other benzodiazepines (etizolam and flualprazolam). To our knowledge, this is the first report to provide concentrations of bromazolam in postmortem blood samples in Canada.Keywords
This publication has 18 references indexed in Scilit:
- A Review of Alprazolam Use, Misuse, and WithdrawalJournal of Addiction Medicine, 2018
- Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’International Journal of Drug Policy, 2017
- The emergence of new psychoactive substance (NPS) benzodiazepines: A reviewDrug Testing and Analysis, 2017
- The Impact of Benzodiazepine Use on Mortality among Polysubstance Users in Vancouver, CanadaPublic Health Reports®, 2016
- A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor ModelInternational Journal of Medicinal Chemistry, 2015
- In vivoprofiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profileBritish Journal of Pharmacology, 2014
- The diagnosis and management of benzodiazepine dependenceCurrent Opinion in Psychiatry, 2005
- Alprazolam is relatively more toxic than other benzodiazepines in overdoseBritish Journal of Clinical Pharmacology, 2004
- Clinical Pharmacology, Clinical Efficacy, and Behavioral Toxicity of Alprazolam: A Review of the LiteratureCNS Drug Reviews, 2004
- 6-Aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines. Influence of 1-substitution on pharmacological activityJournal of Medicinal Chemistry, 1979